Apollo Endosurgery (APEN) Misses Q1 EPS by 7c

Apollo Endosurgery (NASDAQ: APEN) reported Q1 EPS of ($0.47), $0.07 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $15.7 million versus the consensus estimate of $16.02 million.

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Omega Flex (OFLX) Tops Q2 EPS by 27c